Value proposition

Changing the paradigm of osteoarthritis treatment!

CartilaGen Inc. is developing an intra-articular injection of a small-molecule drug capable of preventing post-traumatic osteoarthritis. CartilaGen's solution aims to provide an unprecedented disease-modifying treatment to an area of medicine that remains an unmet medical need.

Osteoarthritis, Biomaterials, and Preventative Medicine